PERP B — Perpetua Medical AB (publ) Share Price
Last trade - 00:00- SEK21.70m
- SEK19.32m
- SEK6.94m
- 13
- 13
- 65
- 17
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.77 | ||
| Price to Tang. Book | 10.62 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 3.13 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -15.69% | ||
| Return on Equity | -31.08% | ||
| Operating Margin | -34.85% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | 1.9 | 8.82 | 10.11 | 9.94 | 6.94 | n/a | n/a | 26.04% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Perpetua Medical AB (publ), formerly Pharmacolog I Uppsala AB (publ), is a Sweden-based medical technology company that develops systems and solutions which aim to optimize and ensure correct and effective treatment with injectable drugs. The Company provides solutions and products that verifies that drugs and narcotics used in surgery have not been tampered with, its solutions make a vital contribution to preventing drug diversion. Its products Pharmacolog Dashboard offers a variety of valuable tools, generating reports and statistical analyses of validated pharmaceuticals. Another product WasteLog is a device that manages the workflow by instantly analyzing the waste and returns of injectable controlled substances.
Directors
- Erik Hedlund CHM (71)
- Mats Hogberg CEO (55)
- LiseLotte Soder CFO (56)
- Kent Obrink DSL (54)
- Susanne Grimsby OTH (58)
- Lars Gusch OTH (45)
- Torbjorn Norberg OTH (54)
- Asa Stroofe OTH
- Olle Johansson IND (67)
- Ragnar Linder IND (66)
- Carl-Johan Spak IND (65)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- February 14th, 2007
- Public Since
- August 6th, 2015
- No. of Employees
- 4
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- OMX Nordic Exchange Stockholm
- Shares in Issue
- 4,521,674
- Address
- Knivstagatan 8, UPPSALA, 753 23
- Web
- https://perpetuamedical.se/
- Phone
- +46 18500101
- Auditors
- Folkesson Rad & Revision AB
Upcoming Events for PERP B
Similar to PERP B
Acarix AB
OMX Nordic Exchange Stockholm
AddLife AB
OMX Nordic Exchange Stockholm
ADDvise AB (publ)
OMX Nordic Exchange Stockholm
ADDvise AB (publ)
OMX Nordic Exchange Stockholm
Arcoma AB
OMX Nordic Exchange Stockholm
FAQ
As of Today at 22:37 UTC, shares in Perpetua Medical AB (publ) are trading at SEK4.80. This share price information is delayed by 15 minutes.
Shares in Perpetua Medical AB (publ) last closed at SEK4.80 and the price had moved by +110.53% over the past 365 days. In terms of relative price strength the Perpetua Medical AB (publ) share price has outperformed the FTSE Global All Cap Index by +105.26% over the past year.
There is no consensus recommendation for this security.
Find out morePerpetua Medical AB (publ) does not currently pay a dividend.
Perpetua Medical AB (publ) does not currently pay a dividend.
Perpetua Medical AB (publ) does not currently pay a dividend.
To buy shares in Perpetua Medical AB (publ) you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of SEK4.80, shares in Perpetua Medical AB (publ) had a market capitalisation of SEK21.70m.
Here are the trading details for Perpetua Medical AB (publ):
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: PERP B
Based on an overall assessment of its quality, value and momentum Perpetua Medical AB (publ) is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Perpetua Medical AB (publ). Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +7.72%.
As of the last closing price of SEK4.80, shares in Perpetua Medical AB (publ) were trading -0.46% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Perpetua Medical AB (publ) PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK4.80.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Perpetua Medical AB (publ)'s management team is headed by:
- Erik Hedlund - CHM
- Mats Hogberg - CEO
- LiseLotte Soder - CFO
- Kent Obrink - DSL
- Susanne Grimsby - OTH
- Lars Gusch - OTH
- Torbjorn Norberg - OTH
- Asa Stroofe - OTH
- Olle Johansson - IND
- Ragnar Linder - IND
- Carl-Johan Spak - IND